Abstract
Novel saponins that retain a free carboxyl group at the C-17 position and various sugars linked at the C-3 position of hederagenin aglycone were synthesized via stereospecific glycosylation. Since these natural products represented by Pulsatilla saponin D (PSD) were obtained in very small amounts, the total synthesis developed in this paper will resolve this problem of scarcity. The two types of synthesized arabinose- and rhamnose-cored saponins showed potent anticancer activity against a human lung cancer cell line (A549), and most disaccharide moiety saponins possessed more potent anti-lung cancer activity. Among the novel PSD analogues containing disaccharide saponins, compound 10i showed anti-lung cancer activity (6.6 μM) that was four-fold more potent than the clinical agent Iressa® (26.08 μM).
Original language | English |
---|---|
Article number | A3 |
Pages (from-to) | 669-677 |
Number of pages | 9 |
Journal | Chemical and Pharmaceutical Bulletin |
Volume | 63 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2015 Sept 1 |
Bibliographical note
Publisher Copyright:© 2015 The Pharmaceutical Society of Japan.
All Science Journal Classification (ASJC) codes
- Chemistry(all)
- Drug Discovery